The results are astonishing
The TOPs will be assessed, as usual, after all payments, including the cancer hospital payment adjustment, have been made for a cost reporting period
Investigation on the inhibitory effect of Wnt-5a on colonic mucosal inflammation in patients with ulcerative colitis
S., Brcic, L., Sever, M., Klicek, R., Radic, B., Drmic, D., Ilic, S., Kolenc, D., Aralica, G., Safic, H., Suran, J., Barisic, I., Dzidic, S., Vrcic, H., & Sebecic, B
The agency declined to evaluate three of them, writing that the nominations did not include sufficient information and that it did not identify clinical studies using BPC-157 in these populations. The 68-page review is entirely about ulcerative colitis, because thats the only proposed use with any human trial behind it
I will say [their reporting on] the business, that was fucking made up